Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Microcephalic primordial dwarfism due to ZNF335 deficiency is characterized by severe antenatal microencephaly, simplified gyration, agenesis of the corpus callosum, absence of basal ganglia (very rare), pontocerebellar atrophy and involvement of the white matter with secondary cerebral atrophy. Congenital cataract, choanal atresia, multiple arthrogryposis and spastic tetraparesis can occur.
Features include always present findings: Severe global developmental delay and Primary microcephaly; and very common findings: Simplified gyral pattern, Microcephaly, Abnormal cerebellum morphology, and Abnormal cerebral morphology and others. 28 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Brain shrinkage (cerebral atrophy), Scarring in the brain (gliosis), Severe global developmental delay |
ZNF335 function has not been fully characterized.
Microcephalic primordial dwarfism due to ZNF335 deficiency is associated with mutations in the ZNF335 gene on chromosome 20.
Genetic testing for ZNF335 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 9 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for microcephalic primordial dwarfism due to ZNF335 deficiency.
4 publications have been identified in PubMed for microcephalic primordial dwarfism due to ZNF335 deficiency. Research spans Basic Science / Preclinical (75%) and Review / Meta-Analysis (25%).
Jiang Q (2026). [PMID: 41970958](https://pubmed.ncbi.nlm.nih.gov/41970958/). *Front Cell Dev Biol*. [Basic Science / Preclinical]
Yeter B (2025). [PMID: 41153337](https://pubmed.ncbi.nlm.nih.gov/41153337/). *Genes (Basel)*. [Basic Science / Preclinical]
Wang J (2024). [PMID: 39344621](https://pubmed.ncbi.nlm.nih.gov/39344621/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Review / Meta-Analysis]
Luo S (2024). [PMID: 38818167](https://pubmed.ncbi.nlm.nih.gov/38818167/). *Heliyon*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles | 4 | Brain shrinkage (cerebral atrophy), Shrinkage of the cerebellum (cerebellar atrophy), Joint stiffness present at birth (arthrogryposis multiplex congenita) |
Head and neck | 2 | Primary microcephaly, Microcephaly |
Eyes | 1 | Cataract |
Growth and development | 1 | Intrauterine growth retardation |
Age of onset: at birth.